{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:23:08Z","timestamp":1758633788010,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbrc.2020.07.024","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T18:33:51Z","timestamp":1596047631000},"page":"910-915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Arsenite suppresses the transcriptional activity of EVI1 through the binding to CCHC-type Zn finger domain"],"prefix":"10.1016","volume":"529","author":[{"given":"Masatoshi","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6802-2992","authenticated-orcid":false,"given":"Yasuko","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Himeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Suzukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1585-8013","authenticated-orcid":false,"given":"Daigo","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.07.024_bib1","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","article-title":"Myelodysplastic syndromes","volume":"111","author":"Nimer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.07.024_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(88)91175-0","article-title":"Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines","volume":"54","author":"Morishita","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.07.024_bib3","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/sj.emboj.7600679","article-title":"Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression","volume":"24","author":"Yuasa","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2020.07.024_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V84.4.1243.1243","article-title":"Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations","volume":"84","author":"Russell","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.07.024_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI21716","article-title":"EVI1 induces myelodysplastic syndrome in mice","volume":"114","author":"Buonamici","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2020.07.024_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2016-02-698118","article-title":"GATA2 regulates dendritic cell differentiation","volume":"128","author":"Onodera","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.07.024_bib7","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1084\/jem.20130751","article-title":"Gata2 is required for HSC generation and survival","volume":"210","author":"de Pater","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2020.07.024_bib8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.leu.2402517","article-title":"GATA-1 and GATA-2 gene expression is related to the severity of dysplasia in myelodysplastic syndrome","volume":"16","author":"Fadilah","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2020.07.024_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbagrm.2017.03.007","article-title":"The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells","volume":"1860","author":"Maicas","year":"2017","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.bbrc.2020.07.024_bib10","first-page":"3345","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells","volume":"89","author":"Chen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.07.024_bib11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In\u00a0vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: as2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.07.024_bib12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.07.024_bib13","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.07.024_bib14","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2005-04-1424","article-title":"NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)","volume":"106","author":"Kerbauy","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.07.024_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.leukres.2011.12.023","article-title":"A\u00a0combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes","volume":"36","author":"Wei","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2020.07.024_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jinorgbio.2016.08.003","article-title":"Kinetics and thermodynamics of zinc(II) and arsenic(III) binding to XPA and PARP-1 zinc finger peptides","volume":"163","author":"Huestis","year":"2016","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.bbrc.2020.07.024_bib17","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1074\/jbc.M805566200","article-title":"Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage","volume":"284","author":"Ding","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.07.024_bib18","doi-asserted-by":"crossref","first-page":"22855","DOI":"10.1074\/jbc.M111.232926","article-title":"Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs","volume":"286","author":"Zhou","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.07.024_bib19","first-page":"1259","article-title":"Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene","volume":"10","author":"Matsugi","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.07.024_bib20","first-page":"4291","article-title":"Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C\/T)AAGA(T\/C)AAGATAA","volume":"13","author":"Delwel","year":"1993","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.07.024_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.lfs.2016.02.054","article-title":"Arsenic trioxide augments all-trans retinoic acid-induced differentiation of HL-60 cells","volume":"149","author":"Sumi","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2020.07.024_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2131\/jts.35.891","article-title":"1,2-Naphthoquinone suppresses lipopolysaccharide-dependent activation of IKKbeta\/NF-kappaB\/NO signaling: an alternative mechanism for the disturbance of inducible NO synthase-catalyzed NO formation","volume":"35","author":"Sumi","year":"2010","journal-title":"J.\u00a0Toxicol. Sci."},{"key":"10.1016\/j.bbrc.2020.07.024_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2011.10.008","article-title":"Alternative splicing variants of human arsenic (+3 oxidation state) methyltransferase","volume":"415","author":"Sumi","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2020.07.024_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2443.2005.00864.x","article-title":"Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway","volume":"10","author":"Minegishi","year":"2005","journal-title":"Gene Cell."},{"key":"10.1016\/j.bbrc.2020.07.024_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncb1717","article-title":"Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway","volume":"10","author":"Lallemand-Breitenbach","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.07.024_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ncb1716","article-title":"RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation","volume":"10","author":"Tatham","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.07.024_bib27","doi-asserted-by":"crossref","first-page":"16595","DOI":"10.1074\/jbc.M109.006387","article-title":"Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells","volume":"284","author":"Percherancier","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.07.024_bib28","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2010-01-261040","article-title":"Autophagy contributes to therapy-induced degradation of the PML\/RARA oncoprotein","volume":"116","author":"Isakson","year":"2010","journal-title":"Blood"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2031411X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2031411X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:53:56Z","timestamp":1757764436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2031411X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0006291X2031411X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.07.024","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arsenite suppresses the transcriptional activity of EVI1 through the binding to CCHC-type Zn finger domain","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}